415 related articles for article (PubMed ID: 17803749)
1. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
Vancíková Z; Dvorák P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.
Paya CV
Clin Infect Dis; 2001 Feb; 32(4):596-603. PubMed ID: 11181123
[TBL] [Abstract][Full Text] [Related]
5. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
Legendre C; Pascual M
Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
[TBL] [Abstract][Full Text] [Related]
6. Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR
Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587
[TBL] [Abstract][Full Text] [Related]
7. Delayed onset CMV disease in solid organ transplant recipients.
Husain S; Pietrangeli CE; Zeevi A
Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
Fisher RA
Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
Griffiths P; Whitley R; Snydman DR; Singh N; Boeckh M;
Herpes; 2008 Oct; 15(1):4-12. PubMed ID: 18983762
[TBL] [Abstract][Full Text] [Related]
10. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
[TBL] [Abstract][Full Text] [Related]
11. Late-onset cytomegalovirus disease in patients with solid organ transplant.
Meylan PR; Manuel O
Curr Opin Infect Dis; 2007 Aug; 20(4):412-8. PubMed ID: 17609602
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection in organ transplant recipients.
Hibberd PL; Snydman DR
Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
14. The case for cytomegalovirus prophylaxis in solid organ transplantation.
Snydman DR
Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
[TBL] [Abstract][Full Text] [Related]
15. Strategies for managing cytomegalovirus in transplant recipients.
Razonable RR
Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
[TBL] [Abstract][Full Text] [Related]
16. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
Humar A; Kumar D; Gilbert C; Boivin G
J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus (CMV)].
Mazeron MC
Rev Prat; 1999 Dec; 49(20):2222-6. PubMed ID: 10731806
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects of CMV infection after stem cell transplantation.
Hebart H; Einsele H
Hum Immunol; 2004 May; 65(5):432-6. PubMed ID: 15172442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
